IGGi-11me, a prodrug that can permeate membranes, is derived from IGGi-11, the inaugural inhibitor targeting the noncanonical activation of heterotrimeric G-protein signaling. By binding to G-protein alpha-subunits (Galphai), IGGi-11 specifically disrupts their interaction with GIV/Girdin, thereby obstructing noncanonical G-protein signaling in tumor cells and hindering the proinvasive characteristics of metastatic cancer cells.
Molekulargewicht:
552.66
Formel:
C25H32N2O8S2
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
